Skip to main content

OptoCeutics

Optoceutics develops gamma light therapy technology to enhance cellular metabolism and promote healing in patients with impaired cellular function. This non-invasive approach provides a targeted solution for improving health outcomes related to various metabolic conditions.

Traction 5/10
HQ unknown
Founded 2018192K+ followers
  • Biotechnology
Updated 2 months ago

Funding

Raised to date

$2.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

$2M across 1 disclosed round

$2M · Seed

Announced Dec 2023

Disclosed cumulative: $2M

5/5

Reported total $2.6M

Incomplete round history. $630K of the $2.6M reported total isn’t matched to a known round (4 known rounds have undisclosed amounts).

Founders

1 founder

Jeppe Sloth Olsen

MedTech Design Engineer & Co-founder

Product

Features

  • Optoceutics develops gamma light therapy technology to enhance cellular metabolism and promote healing in patients with impaired cellular function. This non-invasive approach provides a targeted solution for improving health outcomes related to various metabolic conditions.
This profile is AI-generated and may contain inaccuracies.